We unravel the story of Lucira Health. From its meteoric rise during the pandemic and a $153 million IPO, to a dramatic bankruptcy auction where pharmaceutical giant Pfizer acquired the company for just $36.4 million, and the final, quiet decision less than two years later to shut it all down. It’s a story that reveals just how quickly a pandemic hero can become a cautionary tale.
/
RSS Feed
Leave a Reply
You must be logged in to post a comment.